clinical trial · NCT05814939
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Jiangsu vcare pharmaceutical technology co., LTD·phase2·completed·n = 180
Active Ankylosing SpondylitisVC005 tabletsTofacitinib Citrate TabletsVC005 Tablets Placebo
brief summary
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.
started
Apr 26, 2023
primary completion
May 11, 2024
completion
May 11, 2024
last updated
Jul 29, 2024
official title
A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol